Literature DB >> 21801539

Risk communication methods in hip fracture prevention: a randomised trial in primary care.

Ben Hudson1, Les Toop, Dee Mangin, John Pearson.   

Abstract

BACKGROUND: Treatment acceptance by patients is influenced by the way treatment effects are presented. Presentation of benefits using relative risk increases treatment acceptance compared to the use of absolute risk. It is not known whether this effect is modified by prior presentation of a patient's individualised risk estimate or how presentation of treatment harms by relative or absolute risk affects acceptance. AIM: To compare acceptance of a hypothetical treatment to prevent hip fracture after presentation of the treatment's benefit in relative or absolute terms in the context of a personal fracture risk estimate, and to reassess acceptance following subsequent presentation of harm in relative or absolute terms. DESIGN AND
SETTING: Randomised controlled trial of patients recruited from 10 GPs' lists in Christchurch, New Zealand.
METHOD: Women aged ≥ 50 years were invited to participate. Participants were given a personal 10-year hip fracture risk estimate and randomised to receive information on a hypothetical treatment's benefit and harm in relative or absolute terms.
RESULTS: Of the 1140 women invited to participate 393 (34%) took part. Treatment acceptance was greater following presentation of benefit using absolute terms than relative terms after adjustment forage, education, previous osteoporosis diagnosis, and self-reported risk (OR 1.73, 95% confidence interval [CI] = 1.10 to 2.73, P = 0.018). Presentation of the treatment's harmful effect in relative terms led to a greater proportion of participants declining treatment than did presentation in absolute terms (OR 4.89, 95% CI = 2.3 to 11.0, P<0.001).
CONCLUSION: Presentation of treatment benefit and harm using absolute risk estimates led to greater treatment acceptance than presentation of the same information in relative terms.

Entities:  

Mesh:

Year:  2011        PMID: 21801539      PMCID: PMC3145530          DOI: 10.3399/bjgp11X588439

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN: 0960-1643            Impact factor:   5.386


  17 in total

1.  Prediction of fracture from low bone mineral density measurements overestimates risk.

Authors:  J A Kanis; O Johnell; A Oden; B Jonsson; C De Laet; A Dawson
Journal:  Bone       Date:  2000-04       Impact factor: 4.398

2.  Reducing aversion to side effects in preventive medical treatment decisions.

Authors:  Erika A Waters; Neil D Weinstein; Graham A Colditz; Karen M Emmons
Journal:  J Exp Psychol Appl       Date:  2007-03

3.  Does the frame affect the picture? A study into how attitudes to screening for cancer are affected by the way benefits are expressed.

Authors:  D Sarfati; P Howden-Chapman; A Woodward; C Salmond
Journal:  J Med Screen       Date:  1998       Impact factor: 2.136

4.  Using natural frequencies to improve diagnostic inferences.

Authors:  U Hoffrage; G Gigerenzer
Journal:  Acad Med       Date:  1998-05       Impact factor: 6.893

5.  Provision of information about drug side-effects to patients.

Authors:  D C Berry; P Knapp; D K Raynor
Journal:  Lancet       Date:  2002-03-09       Impact factor: 79.321

6.  Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis.

Authors:  Dennis M Black; Pierre D Delmas; Richard Eastell; Ian R Reid; Steven Boonen; Jane A Cauley; Felicia Cosman; Péter Lakatos; Ping Chung Leung; Zulema Man; Carlos Mautalen; Peter Mesenbrink; Huilin Hu; John Caminis; Karen Tong; Theresa Rosario-Jansen; Joel Krasnow; Trisha F Hue; Deborah Sellmeyer; Erik Fink Eriksen; Steven R Cummings
Journal:  N Engl J Med       Date:  2007-05-03       Impact factor: 91.245

7.  Comparison of two methods of presenting risk information to patients about the side effects of medicines.

Authors:  P Knapp; D K Raynor; D C Berry
Journal:  Qual Saf Health Care       Date:  2004-06

8.  Communicating the benefits of chronic preventive therapy: does the format of efficacy data determine patients' acceptance of treatment?

Authors:  J E Hux; C D Naylor
Journal:  Med Decis Making       Date:  1995 Apr-Jun       Impact factor: 2.583

Review 9.  The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women.

Authors:  J A Kanis; A Oden; O Johnell; H Johansson; C De Laet; J Brown; P Burckhardt; C Cooper; C Christiansen; S Cummings; J A Eisman; S Fujiwara; C Glüer; D Goltzman; D Hans; M-A Krieg; A La Croix; E McCloskey; D Mellstrom; L J Melton; H Pols; J Reeve; K Sanders; A-M Schott; A Silman; D Torgerson; T van Staa; N B Watts; N Yoshimura
Journal:  Osteoporos Int       Date:  2007-02-24       Impact factor: 4.507

Review 10.  Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis.

Authors:  Mark J Bolland; Alison Avenell; John A Baron; Andrew Grey; Graeme S MacLennan; Greg D Gamble; Ian R Reid
Journal:  BMJ       Date:  2010-07-29
View more
  4 in total

1.  Communicating risk to patients and the public.

Authors:  Gurudutt Naik; Haroon Ahmed; Adrian G K Edwards
Journal:  Br J Gen Pract       Date:  2012-04       Impact factor: 5.386

2.  Cost-Effectiveness of Osteoporosis Screening Strategies for Men.

Authors:  Smita Nayak; Susan L Greenspan
Journal:  J Bone Miner Res       Date:  2016-02-10       Impact factor: 6.741

3.  Patients' expectations of screening and preventive treatments.

Authors:  Ben Hudson; Abby Zarifeh; Lorraine Young; J Elisabeth Wells
Journal:  Ann Fam Med       Date:  2012 Nov-Dec       Impact factor: 5.166

Review 4.  Effective communication regarding risk of fracture for individuals at risk of fragility fracture: a scoping review.

Authors:  Charlotte Beaudart; Mickael Hiligsmann; Nannan Li; E Michael Lewiecki; Stuart Silverman
Journal:  Osteoporos Int       Date:  2021-09-24       Impact factor: 4.507

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.